Home > Journals > Medicine > Epilepsie > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Epilepsies
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Epilepsy in systemic lupus and antiphospholid syndrome


Epilepsies. Volume 22, Number 4, 288-93, Décembre 2010, Épilepsie et inflammation

Résumé   Texte intégral  

Author(s) : Laurent Arnaud, Zahir Amoura

Summary : Systemic lupus eythematosus (SLE) is an autoimmune disease characterized by varied clinical signs and the presence of antibodies directed towards the nuclear antigens. Identification of the antiphospolipid syndrome either occurring in the context of an autoimmune disease such SLE (secondary antiphospholipid syndrome) either without any identified disease (primary antiphospholipid syndrome) has received large attention showing that antiphospholipid antibodies (aPL) cause vascular thrombosis with the risk of diverse neurological complications such as convulsions/epilepsy. Recently it has been proposed that aPL could be potentially pathogenic for the neural tissue through the inhibition of the GABA-receptors, indirectly suggesting their role in the pathogenesis of epilepsy.

Keywords : autoimmunity, antiphospholipid syndrome, systemic lupus erythematosus, epilepsy

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]